547 related articles for article (PubMed ID: 12815503)
1. Psychosocial risk factors of HIV morbidity and mortality: findings from the Multicenter AIDS Cohort Study (MACS).
Farinpour R; Miller EN; Satz P; Selnes OA; Cohen BA; Becker JT; Skolasky RL; Visscher BR
J Clin Exp Neuropsychol; 2003 Aug; 25(5):654-70. PubMed ID: 12815503
[TBL] [Abstract][Full Text] [Related]
2. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
3. Race, sex, drug use, and progression of human immunodeficiency virus disease.
Chaisson RE; Keruly JC; Moore RD
N Engl J Med; 1995 Sep; 333(12):751-6. PubMed ID: 7643881
[TBL] [Abstract][Full Text] [Related]
4. [The prognostic markers of survival and progression in HIV-1 infection. A study of CD4+ lymphocytes, antigen p24 and viral load during 3 years in a cohort of 251 patients].
Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T; Lecha N; Rubio Rivas C
An Med Interna; 2000 Oct; 17(10):533-7. PubMed ID: 11109648
[TBL] [Abstract][Full Text] [Related]
5. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
6. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
[TBL] [Abstract][Full Text] [Related]
7. [Survival, progression to AIDS and immunosuppression in HIV-positive individuals before and after the introduction of the highly active antiretroviral therapy (HAART)].
Pezzotti P; Dorrucci M; Donisi A; Cusini M; Mazzarello G; De Luca A; Salassa B; Ursitti MA; Giuliani M; Rezza G;
Epidemiol Prev; 2003; 27(6):348-55. PubMed ID: 15058363
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus in an aging population, a complication of success.
Kirk JB; Goetz MB
J Am Geriatr Soc; 2009 Nov; 57(11):2129-38. PubMed ID: 19793157
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
10. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
[TBL] [Abstract][Full Text] [Related]
11. Adverse psychosocial factors predict poorer prognosis in HIV disease: a meta-analytic review of prospective investigations.
Chida Y; Vedhara K
Brain Behav Immun; 2009 May; 23(4):434-45. PubMed ID: 19486650
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection.
Selwyn PA; Alcabes P; Hartel D; Buono D; Schoenbaum EE; Klein RS; Davenny K; Friedland GH
N Engl J Med; 1992 Dec; 327(24):1697-703. PubMed ID: 1359411
[TBL] [Abstract][Full Text] [Related]
13. Gender-specific differences in the natural history, clinical features, and socioeconomic status of HIV-infected patients: experience of a treatment centre in Vienna.
Armbruster C; Kriwanek S; Vorbach H
Wien Klin Wochenschr; 2000 Sep; 112(17):754-60. PubMed ID: 11042904
[TBL] [Abstract][Full Text] [Related]
14. Mental health disorders and the risk of AIDS-defining illness and death in HIV-infected veterans.
Nurutdinova D; Chrusciel T; Zeringue A; Scherrer JF; Al-Aly Z; McDonald JR; Overton ET
AIDS; 2012 Jan; 26(2):229-34. PubMed ID: 22089375
[TBL] [Abstract][Full Text] [Related]
15. Predictors of symptomatic HIV-associated neurocognitive disorders in universal health care.
McCombe JA; Vivithanaporn P; Gill MJ; Power C
HIV Med; 2013 Feb; 14(2):99-107. PubMed ID: 22994556
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of neurocognitive status and markers of immune activation as predictors of time to death in advanced HIV infection.
Sevigny JJ; Albert SM; McDermott MP; Schifitto G; McArthur JC; Sacktor N; Conant K; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Marder K; Epstein LG
Arch Neurol; 2007 Jan; 64(1):97-102. PubMed ID: 17210815
[TBL] [Abstract][Full Text] [Related]
17. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
18. The natural history of human immunodeficiency virus infection among adults in Mumbai.
Hira SK; Shroff HJ; Lanjewar DN; Dholkia YN; Bhatia VP; Dupont HL
Natl Med J India; 2003; 16(3):126-31. PubMed ID: 12929853
[TBL] [Abstract][Full Text] [Related]
19. Impact of gender on the risk of AIDS-defining illnesses and mortality in Danish HIV-1-infected patients: a nationwide cohort study.
Thorsteinsson K; Ladelund S; Jensen-Fangel S; Larsen MV; Johansen IS; Katzenstein TL; Pedersen G; Storgaard M; Obel N; Lebech AM
Scand J Infect Dis; 2012 Oct; 44(10):766-75. PubMed ID: 22803607
[TBL] [Abstract][Full Text] [Related]
20. Psychiatric considerations in children and adolescents with HIV/AIDS.
Benton TD
Child Adolesc Psychiatr Clin N Am; 2010 Apr; 19(2):387-400, x. PubMed ID: 20478506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
